BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25286769)

  • 1. Applications of human-induced pluripotent stem cells in the investigation of inherited cardiomyopathy.
    Zhao Q; Cai H; Zhan Y; Li B; Hu S; Sun N
    Int J Cardiol; 2014 Dec; 177(2):604-6. PubMed ID: 25286769
    [No Abstract]   [Full Text] [Related]  

  • 2. Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.
    Ross SB; Fraser ST; Semsarian C
    Trends Cardiovasc Med; 2016 Nov; 26(8):663-672. PubMed ID: 27296521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy in inherited and acquired cardiomyopathies.
    Herrey AS
    Best Pract Res Clin Obstet Gynaecol; 2014 May; 28(4):563-77. PubMed ID: 24794214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in induced pluripotent stem cell-derived cardiac cell sheets for tissue engineering.
    Gao B; Matsuura K; Shimizu T
    Biosci Trends; 2019; 13(4):292-298. PubMed ID: 31527326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.
    Ramachandra CJA; Chua J; Cong S; Kp MMJ; Shim W; Wu JC; Hausenloy DJ
    Cardiovasc Res; 2021 Feb; 117(3):694-711. PubMed ID: 32365198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Your heart on a chip: iPSC-based modeling of Barth-syndrome-associated cardiomyopathy.
    Zweigerdt R; Gruh I; Martin U
    Cell Stem Cell; 2014 Jul; 15(1):9-11. PubMed ID: 24996164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Tissue Engineering Models of Inherited and Acquired Cardiomyopathies.
    Turnbull IC; Mayourian J; Murphy JF; Stillitano F; Ceholski DK; Costa KD
    Methods Mol Biol; 2018; 1816():145-159. PubMed ID: 29987817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies.
    Wang G; McCain ML; Yang L; He A; Pasqualini FS; Agarwal A; Yuan H; Jiang D; Zhang D; Zangi L; Geva J; Roberts AE; Ma Q; Ding J; Chen J; Wang DZ; Li K; Wang J; Wanders RJ; Kulik W; Vaz FM; Laflamme MA; Murry CE; Chien KR; Kelley RI; Church GM; Parker KK; Pu WT
    Nat Med; 2014 Jun; 20(6):616-23. PubMed ID: 24813252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.
    Kamdar F; Klaassen Kamdar A; Koyano-Nakagawa N; Garry MG; Garry DJ
    J Card Fail; 2015 Sep; 21(9):761-70. PubMed ID: 25934595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced reconstruction of rat calvarial defects achieved by plasma-treated electrospun scaffolds and induced pluripotent stem cells.
    Ardeshirylajimi A; Dinarvand P; Seyedjafari E; Langroudi L; Adegani FJ; Soleimani M
    Cell Tissue Res; 2013 Dec; 354(3):849-60. PubMed ID: 23955642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes.
    Eschenhagen T; Mummery C; Knollmann BC
    Cardiovasc Res; 2015 Apr; 105(4):424-38. PubMed ID: 25618410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the use of induced pluripotent stem cells (iPSCs) for the regeneration of tracheal cartilage.
    Imaizumi M; Nomoto Y; Sato Y; Sugino T; Miyake M; Wada I; Nakamura T; Omori K
    Cell Transplant; 2013; 22(2):341-53. PubMed ID: 22863018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heart failure as genetic disease: exemplified by cardiomyopathy].
    Katus HA; Vosberg HP
    Internist (Berl); 1993 Oct; 34(10):902-11. PubMed ID: 8225839
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiomyopathy, mitochondria and Barth syndrome: iPSCs reveal a connection.
    Raval KK; Kamp TJ
    Nat Med; 2014 Jun; 20(6):585-6. PubMed ID: 24901565
    [No Abstract]   [Full Text] [Related]  

  • 15. Modeling of human cardiomyopathy with induced pluripotent stem cells.
    Lee YK; Ng KM; Tse HF
    J Biomed Nanotechnol; 2014 Oct; 10(10):2562-85. PubMed ID: 25992409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "The state of the heart": Recent advances in engineering human cardiac tissue from pluripotent stem cells.
    Sirabella D; Cimetta E; Vunjak-Novakovic G
    Exp Biol Med (Maywood); 2015 Aug; 240(8):1008-18. PubMed ID: 26069271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiomyopathies (classification, diagnosis, treatment and prognosis)].
    Ioseliani DG; Nanaziashvili II
    Kardiologiia; 1983 Dec; 23(12):84-8. PubMed ID: 6686854
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
    Gao A; Peng Y; Deng Y; Qing H
    Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced human pluripotent stem cells and advanced therapies: future perspectives for the treatment of haemophilia?
    Liras A
    Thromb Res; 2011 Jul; 128(1):8-13. PubMed ID: 21396685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hear the beat: decellularized mouse heart regenerated with human induced pluripotent stem cells.
    Lin B; Lu TY; Yang L
    Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):135-7. PubMed ID: 24417367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.